Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1989-10-12
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0004-3591
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1186-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2505780-Adolescent,
pubmed-meshheading:2505780-Adult,
pubmed-meshheading:2505780-Buserelin,
pubmed-meshheading:2505780-Drug Evaluation,
pubmed-meshheading:2505780-Female,
pubmed-meshheading:2505780-Humans,
pubmed-meshheading:2505780-Lupus Erythematosus, Systemic,
pubmed-meshheading:2505780-Time Factors
|
pubmed:year |
1989
|
pubmed:articleTitle |
Administration of gonadotropin-releasing hormone analog as adjunctive therapy in women with systemic lupus erythematosus.
|
pubmed:publicationType |
Letter
|